Home Statistical Dictionary Blinding
Blinding
The practice of concealing which treatment condition a study participant, researcher, or outcome assessor has been assigned to, in order to prevent that knowledge from consciously or unconsciously influencing behavior, responses, or outcome assessment.
In Plain English
Blinding, at its core, is just withholding the information of who got what treatment from someone whose behavior or judgment might otherwise be swayed by knowing it. It can apply to participants (single-blind), to both participants and the people assessing their outcomes (double-blind), or in principle to other parties too, statisticians analyzing the data, or data-safety monitoring committees. The underlying reason it matters is that people, including well-intentioned researchers and honest participants, are demonstrably influenced by expectations, participants who know they're getting an active treatment often report feeling better regardless of whether the treatment actually works (the placebo effect), and researchers who know which group is 'supposed' to do better can unconsciously nudge their assessments in that direction, blinding removes the information that could drive either of those distortions.
Definition
Blinding (masking) is the practice of concealing treatment or exposure group assignment from one or more parties involved in a study, participants, the clinicians or researchers delivering treatment, the assessors evaluating outcomes, or the analysts processing the data, to prevent that knowledge from influencing behavior, self-reported outcomes, or outcome assessment, whether consciously or unconsciously. Blinding operates at different levels depending on which parties are masked, single-blind studies conceal assignment only from participants, double-blind studies conceal it from both participants and assessors/researchers, and less commonly, triple-blind designs additionally conceal assignment from the statisticians analyzing the outcome data (guarding against analytical choices being subtly influenced by group-outcome patterns); blinding is one of the standard companion safeguards to randomization in a well-designed randomized controlled trial, since randomization alone controls for confounding but does nothing to prevent expectation-driven distortions in reporting or assessment, blinding is specifically what addresses those additional threats to validity.
Properties
- Blinding and randomization address genuinely different threats to a study's validity, randomization balances measured and unmeasured confounders between groups, while blinding prevents expectation effects (the placebo effect, assessment bias) from distorting outcomes within an already-balanced comparison, a well-designed RCT typically uses both together precisely because they protect against different problems.
- The specific level of blinding achieved, single, double, or (less commonly) triple-blind, should be explicitly reported in any study relying on it, since the strength of protection against expectation-driven bias differs meaningfully between these levels, a single-blind study still leaves assessor expectation bias fully unaddressed.
- Blinding is not always achievable, interventions with obvious, unmaskable physical effects or side effects (surgery, an intervention with a very distinctive taste or sensation) can make true blinding of participants difficult or impossible, in such cases researchers often rely on partial safeguards, such as blinded, independent outcome assessment, to preserve at least some of blinding's protective value.
At a Glance